Erratum: Genetically engineered models have advantages over xenografts for preclinical studies (Cancer Research (April 1, 2006) 66 (3355-3359))

O. J. Becher; E. C. Holland

doi:10.1158/0008-5472.CAN-66-17-COR

Erratum: Genetically engineered models have advantages over xenografts for preclinical studies (Cancer Research (April 1, 2006) 66 (3355-3359))

O. J. Becher, E. C. Holland

Pediatrics

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Number of pages	1
Journal	Cancer Research
Volume	66
Issue number	17
DOIs	https://doi.org/10.1158/0008-5472.CAN-66-17-COR
State	Published - Sep 1 2006

ASJC Scopus subject areas

Cancer Research
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/0008-5472.CAN-66-17-COR

Cite this

@article{7a10ad12236146cfb508f919241f2793,

title = "Erratum: Genetically engineered models have advantages over xenografts for preclinical studies (Cancer Research (April 1, 2006) 66 (3355-3359))",

author = "Becher, {O. J.} and Holland, {E. C.}",

year = "2006",

month = sep,

day = "1",

doi = "10.1158/0008-5472.CAN-66-17-COR",

language = "English (US)",

volume = "66",

journal = "Journal of Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research Inc.",

number = "17",

}

TY - JOUR

T1 - Erratum

T2 - Genetically engineered models have advantages over xenografts for preclinical studies (Cancer Research (April 1, 2006) 66 (3355-3359))

AU - Becher, O. J.

AU - Holland, E. C.

PY - 2006/9/1

Y1 - 2006/9/1

UR - http://www.scopus.com/inward/record.url?scp=33749003133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749003133&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-66-17-COR

DO - 10.1158/0008-5472.CAN-66-17-COR

M3 - Comment/debate

AN - SCOPUS:33749003133

VL - 66

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 17

ER -

Erratum: Genetically engineered models have advantages over xenografts for preclinical studies (Cancer Research (April 1, 2006) 66 (3355-3359))

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this